Terms: = Gastric cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
118 results:
1. E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming.
Zou G; Huang Y; Zhang S; Ko KP; Kim B; Zhang J; Venkatesan V; Pizzi MP; Fan Y; Jun S; Niu N; Wang H; Song S; Ajani JA; Park JI
J Exp Med; 2024 Apr; 221(4):. PubMed ID: 38411616
[TBL] [Abstract] [Full Text] [Related]
2. Transversal Perspectives of Integrative Oncology Care in gastric and Lobular Breast cancer.
Giunta EF; Arrichiello G; Pappalardo A; Federico P; Petrillo A
Cancer Treat Res; 2023; 188():89-104. PubMed ID: 38175343
[TBL] [Abstract] [Full Text] [Related]
3. Robotic Vagus-Sparing Total Gastrectomy for cdh1 Gene Mutation treatment.
Chan DL; Talbot ML
J Vis Exp; 2023 Dec; (202):. PubMed ID: 38145373
[TBL] [Abstract] [Full Text] [Related]
4. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
5. Synergism of FAK and ROS1 inhibitors in the treatment of
Gao J; Yao Y; Liu C; Xie X; Li D; Liu P; Wang Z; Zhang B; Ren R
Int J Biol Sci; 2023; 19(9):2711-2724. PubMed ID: 37324948
[No Abstract] [Full Text] [Related]
6. cdh1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract] [Full Text] [Related]
7. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
Lim HJ; Zhuang L; Fitzgerald RC
J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer.
Kung CY; Fang WL; Hung YP; Huang KH; Chen MH; Chao Y; Lin SC; Li AF; Lo SS; Wu CW
Aging (Albany NY); 2023 Feb; 15(3):777-790. PubMed ID: 36779847
[TBL] [Abstract] [Full Text] [Related]
9. First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors.
Tsimberidou AM; Vo HH; Beck J; Shia CS; Hsu P; Pearce TE
JCO Precis Oncol; 2023 Jan; 7():e2200496. PubMed ID: 36701651
[TBL] [Abstract] [Full Text] [Related]
10. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica.
Liu Z; Hong LL; Zheng JS; Ling ZN; Zhang ZL; Qi YN; Zhang XY; Zhu TY; Wang JL; Han J; Chen XL; Yu QM; Wang S; Li P; Ling ZQ
Gastric Cancer; 2023 Mar; 26(2):203-219. PubMed ID: 36450891
[TBL] [Abstract] [Full Text] [Related]
12. Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse gastric cancer.
Peng K; Zhang F; Wang Y; Sahgal P; Li T; Zhou J; Liang X; Zhang Y; Sethi N; Liu T; Zhang H; Bass AJ
Clin Cancer Res; 2023 Jan; 29(1):197-208. PubMed ID: 36278961
[TBL] [Abstract] [Full Text] [Related]
13. Pathological and oncological outcomes of pylorus-preserving versus conventional distal gastrectomy in early gastric cancer: a systematic review and meta-analysis.
Hou S; Liu F; Gao Z; Ye Y
World J Surg Oncol; 2022 Sep; 20(1):308. PubMed ID: 36153587
[TBL] [Abstract] [Full Text] [Related]
14. Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer.
Seidlitz T; Schmäche T; Garcίa F; Lee JH; Qin N; Kochall S; Fohgrub J; Pauck D; Rothe A; Koo BK; Weitz J; Remke M; Muñoz J; Stange DE
EMBO Mol Med; 2022 Oct; 14(10):e15705. PubMed ID: 35993110
[TBL] [Abstract] [Full Text] [Related]
15. Validation of the Memorial Sloan Kettering gastric cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time?
Nakauchi M; Court CM; Tang LH; Gönen M; Janjigian YY; Maron SB; Molena D; Coit DG; Brennan MF; Strong VE
J Am Coll Surg; 2022 Aug; 235(2):294-304. PubMed ID: 35839406
[TBL] [Abstract] [Full Text] [Related]
16. Establishment and Validation for Predicting the Lymph Node Metastasis in Early gastric Adenocarcinoma.
Li X; Zhou H; Zhao X; Peng H; Luo S; Feng J; Heng J; Liu H; Ge J
J Healthc Eng; 2022; 2022():8399822. PubMed ID: 35812896
[TBL] [Abstract] [Full Text] [Related]
17. The gastric cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in gastric cancer.
Almeda AF; Grimes SM; Lee H; Greer S; Shin G; McNamara M; Hooker AC; Arce MM; Kubit M; Schauer MC; Van Hummelen P; Ma C; Mills MA; Huang RJ; Hwang JH; Amieva MR; Han SS; Ford JM; Ji HP
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1693-1700. PubMed ID: 35771165
[TBL] [Abstract] [Full Text] [Related]
18. The upregulation of circFNDC3B aggravates the recurrence after endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) patients.
Zhang J; Bai J; Zhu H; Li W; An Q; Wang D
Sci Rep; 2022 Apr; 12(1):6178. PubMed ID: 35418175
[TBL] [Abstract] [Full Text] [Related]
19. Global distribution of prophylactic total gastrectomy in E-cadherin (cdh1) mutations.
Corso G; Magnoni F; Nicastro V; Bagnardi V; Trovato CM; Veronesi P
Semin Oncol; 2022 Apr; 49(2):130-135. PubMed ID: 35393124
[TBL] [Abstract] [Full Text] [Related]
20.
Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
[TBL] [Abstract] [Full Text] [Related]
[Next]
